(PharmaNewsWire.Com, September 13, 2019 ) Market Overview: Cutaneous leishmaniasis is also known as oriental sore, tropical sore, Aleppo boil, Delhi Boil or desert boil. It is the most common form of leishmaniasis affecting humans. The cutaneous form presents with skin ulcers. It is a skin infection caused by a single-celled parasite that is transmitted by the bite of a phlebotomine sandfly. There are about twenty species of Leishmania that cause cutaneous leishmaniasis.
Market Dynamics: Research and development by prominent manufacturers of this market to introduce new drugs into the market, which are more effective as well as affordable is the key factor driving the global cutaneous and systemic leishmaniasis market.
However, the treatment for cutaneous and systemic leishmaniasis is very expensive and can cause serious adverse effects such as vomiting, nausea, anorexia, myalgia, abdominal pain, headache, arthralgia, and lethargy and can rarely cause the severe reaction of fatal cardiac arrhythmia. These factors are hampering the global cutaneous and systemic leishmaniasis market growth.
Market Segmentation: By Drug Class Pentavalent Antimonials Anti-fungal Drugs Antimicrobial / Anti-leishmanial
By Route of Administration Oral Topical Injections
By Distribution Channel Hospital Pharmacies Online Pharmacies Retail Pharmacies
Geographical Analysis: By Geography, the market is segmented into: North America Europe South America Asia Pacific The Middle East and Africa
Competitive Analysis: Key Players: GlaxoSmithKline Plc.* Gilead Sciences, Inc. Profounda Pharmaceuticals Knight Therapeutics Inc. Janssen Global Services, LLC Albert David Ltd Others
About Us: DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
